Nucelion Therapeutics, VeGen Bio Partner on CAR-T Therapy The Story: Nucelion Therapeutics and VeGen Bio have partnered to transfer technology and manufacture VL-2511, a Phase II dual-target CAR-T the...
Key Highlights: Implications: Qfitlia’s Indian authorization strengthens Sanofi’s haemophilia portfolio with an antithrombin-lowering approach that offers protection for haemophilia A and ...
